Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Operating activities:    
Net income $ 1,000 $ 12,323
Adjustments to reconcile net income to net cash provided by operating activities    
Bad debt (recovery) expense (1,186) 3,041
Depreciation and amortization expense 21,989 18,167
Amortization of debt issuance costs 221 211
Accretion of acquisition liabilities   36
Deferred taxes (4,572) (3,912)
Stock-based compensation expense 12,100 3,561
Interest expense (income) 130 (36)
Change in fair value of contingent consideration 57 (949)
Offering costs 21,797 1,852
Other 661 742
Changes in operating assets and liabilities net of effect of business combinations    
Trade receivables 690 (11,633)
Prepaid expenses and other current assets 4,590 (3,457)
Other non-current assets (162) (9)
Trade payables 425 1,881
Accrued expenses (684) 2,081
Other current liabilities 2,747 (7,143)
Other non-current liabilities (1,369) 1,082
Net cash provided by operating activities 58,434 17,838
Investing activities:    
Purchase of property, plant and equipment (5,499) (6,545)
Acquisition of businesses, net of cash acquired (24,323)  
Net cash (used in) investing activities (29,822) (6,545)
Financing activities:    
Payments of long-term debt (22,000) (563)
Payment of contingent consideration related to Zentrick acquisition   (601)
Proceeds from common stock issued upon exercise of stock options 5,514 383
Proceeds from common stock issued under employee purchase plan   425
Proceeds from issuance of common stock upon initial public offering 269,390  
Proceeds from issuance of common stock in connection with concurrent private placement 30,000  
Payments related to offering costs (21,797) (1,230)
Capital lease payments (1,222) (1,242)
Shares repurchased for settlement of employee tax withholdings (1,802)  
Net cash provided by (used in) financing activities 258,033 (4,911)
Effect of exchange rate changes on cash and cash equivalents and restricted cash (173) (38)
Net increase in cash, cash equivalents, and restricted cash 286,472 6,344
Cash, cash equivalents, and restricted cash - Beginning of period 33,395 11,342
Cash, cash equivalents, and restricted cash - End of period 319,867 17,686
Supplemental cash flow information:    
Cash paid for taxes 5,586 14,901
Cash paid for interest 580 2,692
Non-cash investing and financing activities:    
Conversion of Series A preferred stock to common stock in connection with the initial public offering 610  
Treasury stock reissued upon the conversion of Series A preferred stock to common stock 260,686  
Acquisition of equipment under capital lease 1,518 973
Capital assets financed by accounts payable 41 1,313
Offering costs included in accounts payable and accrued expense   772
Leiki    
Financing activities:    
Deferred payment related to acquisition   (2,033)
Zentrick    
Financing activities:    
Deferred payment related to acquisition $ (50) $ (50)